Asian Spectator

Men's Weekly

.

Eleva Enters Clinical Development of Difficult-To-Express High...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
FREIBURG, Germany, Oct. 12, 2021 /PRNewswire-AsiaNet/ -- Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, as well as in collaboration with pharmaceutical partners. Its moss-based platform is ideally suited to produ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

‘Slow science’ lebih cocok untuk riset bidang sosial humaniora di Indonesia

● ‘Slow science’ perlu diterapkan untuk melawan tren “menyampah” (‘junkification’) dalam riset dan publikasi ilmiah.● Riset sosial humaniora membutuhkan...

Blunder Dewan Perdamaian cerminan diplomasi nirkaidah ala Prabowo

Presiden Prabowo Subianto dan sejumlah kepala negara lainnya duduk bersama usai menandatangani Board of Peace (BoP) Charter yang diinisiasi oleh Presiden Amerika Serikat Donald Trump di Davos, Swiss, ...

Bahaya normalisasi doksing: Warganet bisa kebablasan jadi ‘hakim’ moral

(Kenary820/Shutterstock)● Warganet kerap melakukan ‘doxing’ dan merasa berhak menghukum orang yang menurut mereka bersalah.● Doksing merupakan pelanggaran privasi dan termasuk ...